Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Insulin Delivery Dec 13 | 2019Tandem Control IQ Approved as first "iAlgorithm" DevicePurchase Blast
$599
Posted in: SGLT2i Dec 13 | 2019Jardiance EMPERIAL Studies Fail to Show HF Symptom ImprovementPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery, Other Dec 12 | 2019Teplizumab Regulatory Update; Sanofi Partners with Biocorp; Livongo Preferred on ESI; Omnipod Horizon Pivotal Trial Initiated; Glooko Partners with Mellitus HealthPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal Dec 12 | 2019Would AZ, Teva, or Mylan/Upjohn Buy Sanofi's DCV Business?Purchase Blast
$599
Posted in: Basal Insulin, Glucagon, Glucose Monitoring, Insulin Delivery Dec 11 | 2019Xeris Positive Ph2 Data in PBH; Oramed Partnership with Tianhui; Glooko Privacy Shield CertificationPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Glucose Monitoring, Insulin Delivery, Other Dec 10 | 2019Sanofi To Move Away From Diabetes/CV; Sanofi 2019 Capital Markets DayPurchase Blast
$599
Posted in: Glucagon, Glucose Monitoring, Insulin Delivery Dec 10 | 2019Beta Bionics's iLet Breakthrough Designation; Roche Receives CE Mark for Novel BG Test; Glooko Receives ISO 13485 CertificationPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, GLP-1RA Dec 09 | 2019High-Dose Trulicity Filed in EU (CHMP Agenda December 9-12)Purchase Blast
$599
Posted in: Bolus Insulin Dec 05 | 2019Arecor uRAI (AT247) Positive Topline ResultsPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA Dec 04 | 2019Tirzepatide Ph3 Obesity Program Initiated (SURMOUNT-1)Purchase Blast
$599
Posted in: Basal Insulin Dec 04 | 2019Positive Lannett Bs-Glargine Ph1 Results; Zealand Initiates 2nd Ph3 CHI StudyPurchase Blast
$599
Posted in: Glucose Monitoring Dec 04 | 2019Dario BGM System Distributed on Walmart.com; Shares Climb ~50%Purchase Blast
$599
Posted in: Glucose Monitoring, Other Dec 02 | 2019Senseonics Launches Non-Adjunctive Claim; Dexcom Data Transmission Issue; Onduo RWE PublishedPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin Nov 27 | 2019Thoughts on FDA Bs-Insulin Draft Guidance; Did Development Just Get Easier?Purchase Blast
$599
Posted in: Other Nov 26 | 2019Poxel Reports Positive Imeglimin Ph3 Japan Topline ResultsPurchase Blast$599
Posted in: Glucose Monitoring Nov 25 | 2019Dario Expands Retail Presence For Connected BGMPurchase Blast
$599
Posted in: Glucose Monitoring Nov 22 | 2019Lifescan Wins Patent Dispute vs. Pharma Tech SolutionsPurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
